Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引：0
作者：
Wei-Lin Liang
Bo Liang
机构：
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [41] Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern
    Michelakis, E. D.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (04) : 717 - 721
  • [42] Soluble Guanylyl Cyclase Activators-Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
    Grzesk, Grzegorz
    Witczynska, Adrianna
    Weglarz, Magdalena
    Wolowiec, Lukasz
    Nowaczyk, Jacek
    Grzesk, Elzbieta
    Nowaczyk, Alicja
    MOLECULES, 2023, 28 (02):
  • [43] Praliciguat Soluble guanylate cyclase activator Treatment of heart failure with preserved ejection fraction Treatment of diabetic nephropathy
    Rana, K.
    Reid, J.
    Choksi, R. R.
    Lewis, T.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (04) : 277 - 286
  • [44] Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
    Follmann, Markus
    Ackerstaff, Jens
    Redlich, Gorden
    Wunder, Frank
    Lang, Dieter
    Kern, Armin
    Fey, Peter
    Griebenow, Nils
    Kroh, Walter
    Becker-Pelster, Eva-Maria
    Kretschmer, Axel
    Geiss, Volker
    Li, Volkhart
    Straub, Alexander
    Mittendorf, Joachim
    Jautelat, Rolf
    Schirok, Hartmut
    Schlemmer, Karl-Heinz
    Lustig, Klemens
    Gerisch, Michael
    Knorr, Andreas
    Tine, Hanna
    Mondritzki, Thomas
    Truebel, Hubert
    Sandner, Peter
    Stasch, Johannes-Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (12) : 5146 - 5161
  • [45] Role of guanylate cyclase modulators in decompensated heart failure
    Veselin Mitrovic
    Adrian F. Hernandez
    Markus Meyer
    Mihai Gheorghiade
    Heart Failure Reviews, 2009, 14 : 309 - 319
  • [46] Soluble GC stimulators and activators: Past, present and future
    Sandner, Peter
    Follmann, Markus
    Becker-Pelster, Eva
    Hahn, Michael G.
    Meier, Christian
    Freitas, Cecilia
    Roessig, Lothar
    Stasch, Johannes-Peter
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (21) : 4130 - 4151
  • [47] Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)
    Xia, Juan
    Hui, Nan
    Tian, Lei
    Liang, Chengyuan
    Zhang, Jie
    Liu, Jifang
    Wang, Jun
    Ren, Xiaodong
    Xie, Xiaolin
    Wang, Kun
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [48] Role of guanylate cyclase modulators in decompensated heart failure
    Mitrovic, Veselin
    Hernandez, Adrian F.
    Meyer, Markus
    Gheorghiade, Mihai
    HEART FAILURE REVIEWS, 2009, 14 (04) : 309 - 319
  • [49] Qifu yixin prescription ameliorates cardiac fibrosis by activating soluble guanylate cyclase (sGC) in heart failure
    Xu, Zhaohui
    Yang, Jiahui
    Hu, Yinqin
    Wan, Qiqi
    Wang, Xinting
    Lu, Cheng
    Liu, Yongming
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 340
  • [50] Cardiovascular Effects of Stimulators of Soluble Guanylate Cyclase Administration: A Meta-analysis of Randomized Controlled Trials
    Cosimo Andrea Stamerra
    Paolo Di Giosia
    Paolo Giorgini
    Tannaz Jamialahmadi
    Amirhossein Sahebkar
    Current Atherosclerosis Reports, 2024, 26 : 177 - 187
12345